Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...

Immune Response Against Viral Pathogens

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

Viruses with RNA Genomes

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Methylation plus alpha-fetoprotein blood test for early detection of HCC in at-risk populations.

Hepatology communications·2026

Same author

A Major Step toward a Cure for Hepatitis B Infection.

The New England journal of medicine·2026

Same author

Hepatitis B: A Review.

JAMA·2026

Same author

Validation of longitudinal biomarker screening algorithms for HCC detection in patients with cirrhosis.

Hepatology communications·2026

Same author

A Self-Reported Electronic Body Map Identifies Distinct Clinical Pain Phenotypes in Chronic Pancreatitis.

Clinical and translational gastroenterology·2026

Same author

Animal Naming Test Predicts Future Overt Hepatic Encephalopathy.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026

Search research articles

Related Experiment Video

Updated: Mar 13, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Interferon Treatment for Hepatitis B.

Monica A Konerman¹, Anna S Lok¹

¹Division of Gastroenterology, Department of Internal Medicine, University of Michigan Health System, 1500 East Medical Center Drive, Ann Arbor, MI 48109, USA.

Clinics in Liver Disease

|October 16, 2016

Summary

Interferon (IFN) therapy offers unique benefits for chronic hepatitis B virus (HBV) infection, including finite treatment duration and higher antigen clearance rates. However, potential adverse effects and patient contraindications require careful consideration.

Keywords:

Chronic hepatitis B Cirrhosis Hepatitis B e antigen Hepatitis B surface antigen Hepatitis B virus genotype Hepatocellular carcinoma

More Related Videos

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons

Published on: August 23, 2016

Related Experiment Videos

Last Updated: Mar 13, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons

Published on: August 23, 2016

Area of Science:

Hepatology
Virology
Immunology

Background:

Chronic hepatitis B virus (HBV) infection poses a significant global public health challenge.
Current treatments include interferon (IFN) and nucleos(t)ide analogs (NUCs).

Purpose of the Study:

To review the mechanisms of action, efficacy, and clinical applications of IFN therapy for chronic HBV infection.
To compare the benefits and drawbacks of IFN therapy against NUCs.

Main Methods:

Literature review of existing studies on IFN therapy for HBV.
Analysis of clinical trial data regarding IFN efficacy and safety.

Main Results:

IFN therapy provides a finite treatment duration, unlike NUCs.
IFN demonstrates higher rates of hepatitis Be antigen and surface antigen clearance compared to NUCs.
Potential adverse effects and contraindications for IFN therapy exist, particularly in patients with advanced liver disease or comorbidities.

Conclusions:

IFN therapy is a valuable option for chronic HBV, offering distinct advantages.
Careful patient selection is crucial to maximize benefits and minimize risks associated with IFN treatment.